Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone with thrombolysis in acute ischemic stroke
IRCT20210530051440N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of edaravone in ischemic stroke (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: National Institutes of Health Stroke Scale, In-hospital mortality and 2 more. Started Jun 2021; status: completed.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20210530051440N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210530051440N1.